Clinical significance of hTERC gene amplification detection by FISH in the screening of cervical lesions

Abstract

This study evaluated the clinical significance of hTERC gene amplification detection by fluorescence in situ hybridization (FISH) in the screening of cervical lesions. Cervical specimens of 50 high risk patients were detected by thin liquid-based cytology. The patients whose cytological results were classified as ASCUS or above were subjected to the subsequent colposcopic biopsies. Slides prepared from these 50 cervical specimens were analyzed for hTERC gene amplification using interphase FISH with the two-color hTERC probe. The results of the cytological analysis and those of subsequent biopsies, when available, were compared with the FISH-detected hTERC abnormalities. It was found that the positive rates of hTERC gene amplification in NILM, ASCUS, LSIL, HSIL, and SCC groups were 0.00, 28.57%, 57.14%, 100%, and 100%, respectively. The positive rates of hTERC gene amplification in HSIL and SCC groups were significantly higher than those in NILM, ASCUS and LSIL groups (all P<0.05). The mean percentages of cells with hTERC gene amplification in NILM, ASCUS, LSIL, HSIL, and SCC groups were 0.00, 10.50%, 36.00%, 79.00%, and 96.50%, respectively. Patients with HSIL or SCC cytological diagnoses had significantly higher mean percentages of cells with hTERC gene amplification than did patients with NILM, ASCUS or LSIL cytological diagnoses (all P<0.05). It was concluded that two-color interphase FISH could detect hTERC gene amplification to accurately distinguish HSIL and ISIL of cervical cells. It may be an adjunct to cytology screening, especially high-risk patients.

Keywords

fluorescence in situ hybridization / cervical lesions / hTERC gene

References

[1] BaldwinP., LaskeyR., ColemanN.. Translational approaches to improving cervical screening. Nat Rev Cancer, 2003, 3: 217-226

[2] Reesink-PetersN., HelderM.N., WismanG.B., et al. . Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia. J Clin Pathol, 2003, 56: 31-35

[3] von Knebel DoeberitzM.. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer, 2002, 38: 2229-2242

[4] MelsheimerP., VinokurovaS., WentzensenN., et al. . DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri. Clin Cancer Res, 2004, 10: 3059-3063

[5] KirchhoffM., RoseH., PetersenB.L., et al. . Comparative genomic hybridization reveals non-random chromosomal aberrations in early preinvasive cervical lesions. Cancer Genet Cytogenet, 2001, 129: 47-51

[6] StoltzfusP., Heselmeyer-HaddadK., CastroJ., et al. . Gain of chromosome 3q is an early and consistent genetic aberration in carcinomas of the vulva. Int J Gynecol Cancer, 2005, 15: 120-126

[7] The 1991 Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda Workshop. JAMA, 1991,287:2114–2119

[8] HuangF.Y., KwokY.K.Y., LauE.T., et al. . Genetic abnormalities and HPV status in cervical and vulvar squamous cell carcinomas. Cancer Genet Cytogenet, 2005, 157: 42-48

[9] SugitaM., TanakaN., DavidsonS., et al. . Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung. Cancer Gen Cytogenet, 2000, 117: 9-18

[10] MeyersonM.. Role of telomerase in normal and cancer cells. J Clin Oncol, 2000, 18: 2626-2634

[11] GuilleretI., YanP., GuillouL.. The human telomerase RNA gene (hTERC) is regulated during carcinogenesis but is not dependent on DNA methylation. Carcinogenesis, 2002, 12: 2025-2030

[12] MarzanoR., CorradoG., MerolaR., et al. . Analysis of chromosomes 3, 7, X and EGFR gene in uterine cervical cancer progression. Eur J Cancer, 2004, 40: 1624-1629

[13] MéhesG., SpeichN., BollmannM., et al. . Chromosomal aberrations accumulate in polyploidy cells of high-grade squamous intraepithelial lesions (HSIL). Pathol Oncol Res, 2004, 10: 142-148

[14] VolpiE.V., BridgerJ.M.. FISH glossary: an overview of the fluorescence in situ hybridization technique. Biotechniques, 2008, 45: 385-390

[15] CarawayN.P., KhannaA., DawlettM., et al. . Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma. Gynecol Oncol, 2008, 110: 37-42

[16] Heselmeyer-HaddadK., JanzV., CastleP.E., et al. . Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia. Am J Pathol, 2003, 163: 1405-1416

[17] Heselmeyer-HaddadK., SommerfeldK., WhiteN.M., et al. . Genomic amplification of the human telomerase gene (TERC) in Pap smears predicts the development of cervical cancer. Am J Pathol, 2005, 166: 1229-1238

[18] zur HausenH.. Papillomaviruses and cancer: from basic studies to clinical application. Nature Rev Cancer, 2002, 2: 342-350

[19] RiethdorfS., RiethdorfL., SchulzG., et al. . Relationship between telomerase activation and HPV 16/18 oncogene expression in squamous intraepithelial lesions and squamous cell carcinomas of the uterine cervix. Int J Gynecol Pathol, 2001, 20: 177-185

[20] LedwabaT., DlaminiZ., NaickerS., et al. . Molecular genetics of human cervical cancer: role of papillomavirus and the apoptotic cascade. Biol Chem, 2004, 385: 671-682

[21] WentzensenN., VinokurovaS., von Knebel DoeberitzM.. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res, 2004, 64: 3878-3884

[22] SnijdersP.J., SteenbergenR.D., HeidemanD.A., et al. . HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol, 2006, 208: 152-164

[23] EvansM.F., CooperK.. Human papillomavirus integration: detection by in situ hybridization and potential clinical application. J Pathol, 2004, 202: 1-4

[24] HopmanA.H., TheelenW., HommelbergP.P., et al. . Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer. J Pathol, 2006, 210: 412-419